Sadegheh Haghshenas, Hidde J Bout, Josephine M Schijns, Michael A Levy, Jennifer Kerkhof, Pratibha Bhai, Haley McConkey, Zandra A Jenkins, Ella M Williams, Benjamin J Halliday, Sylvia A Huisman, Peter Lauffer, Vivian de Waard, Laura Witteveen, Siddharth Banka, Angela F Brady, Elena Galazzi, Julien van Gils, Anna C E Hurst, Frank J Kaiser, Didier Lacombe, Antonio F Martinez-Monseny, Patricia Fergelot, Fabíola P Monteiro, Ilaria Parenti, Luca Persani, Fernando Santos Simarro, Brittany N Simpson, Mariëlle Alders, Stephen P Robertson, Bekim Sadikovic, Leonie A Menke
CREB-binding protein (CBP, encoded by CREBBP) and its paralog E1A-associated protein (p300, encoded by EP300) are involved in histone acetylation and transcriptional regulation. Variants that produce a null allele or disrupt the catalytic domain of either protein cause Rubinstein-Taybi syndrome (RSTS), while pathogenic missense and in-frame indel variants in parts of exons 30 and 31 cause phenotypes recently described as Menke-Hennekam syndrome (MKHK). To distinguish MKHK subtypes and define their characteristics, molecular and extended clinical data on 82 individuals (54 unpublished) with variants affecting CBP (n=71) or p300 (n=11) (NP_004371...
March 28, 2024: HGG advances